HENSON HEIDI bought CATX
March 3, 2025 · Form 4 insider transaction
HENSON HEIDI bought 50,000 shares of Perspective Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderHENSON HEIDI
Role—
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2025
Filing dateMarch 5, 2025
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025.; Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date.